NCT04614194View on ClinicalTrials.gov

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2028

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

Oral. Tablets should be taken at the same times every day, with or without food.

DRUG

Abemaciclib

Oral. Tablets should be taken at the same times every day, with or without food.

Trial Locations (2)

75039

NOT_YET_RECRUITING

Parkland Hospital, Dallas

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

University of Texas Southwestern Medical Center

OTHER